To investigate whether increasing CDA levels in vivo sensitizes SAMHD1-deficient cells to PNPi, we established CEM-YFP control and CEM-CDA bilateral subcutaneous tumors in NCG mice and initiated PNPi treatment once tumor volumes reached 100 mm3 (Figure 4D). This evidence concerns the gene SAMHD1 and neoplasm.